MK-906

Known as: MK 906, MK906 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2010
02419892010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Recent studies suggest that 5 alpha-reductase type 2 (5 alpha R2) rather than 5 alpha R1 plays a key role in the pathogenesis of… (More)
Is this relevant?
1994
1994
In many turtles the temperature during the middle of incubation determines the gonadal sex of the hatchling. In the red-eared… (More)
Is this relevant?
1993
1993
  • The Prostate
  • 1993
The effects of finasteride, a potent 5 alpha-reductase inhibitor, were assessed in 750 patients with benign prostatic hyperplasia… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
The enzyme steroid 5 alpha-reductase catalyzes the conversion of testosterone into the more potent androgen, dihydrotestosterone… (More)
Is this relevant?
1992
1992
A total of 28 untreated patients with asymptomatic, stage D prostate cancer was randomized in a double-blinded fashion to receive… (More)
Is this relevant?
1991
1991
The hormonal effects following the acute (single dose) administration of a 4-azasteroid inhibitor of 5 alpha-reductase (MK-906… (More)
Is this relevant?
1991
1991
  • Journal of andrology
  • 1991
Finasteride (MK-906) is a 5 alpha-reductase inhibitor that reduces circulating dihydrotestosterone (DHT) levels without lowering… (More)
Is this relevant?
1991
1991
Male rats bearing implants of the Dunning rat prostatic carcinoma, R-3327, were used in a 42-day study to determine the effect of… (More)
Is this relevant?
1990
1990
Finasteride, a 5 alpha-reductase inhibitor, was administered to normal male volunteers in a blinded placebo-controlled study at… (More)
Is this relevant?
1989
1989
To determine the hormonal effects of MK-906, an orally active 5 alpha-reductase inhibitor, on serum androgens and androgen… (More)
Is this relevant?